Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neurogastroenterol Motil
Huvudupphovsmän: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Society of Neurogastroenterology and Motility 2018
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://ncbi.nlm.nih.gov/pubmed/29605979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk